drugset / Trial / NCT02652052
Hematopoietic Stem Cell Transplant Survivors Study
RandomizedParallel-groupOpen-labelSupportive care
Summary
The investigators hope to find the proof of principle concept from this pilot study so that the investigators can design a clinical trial based on the results of the explanatory hypothesis.
Timeline
- Start
- 2016-03-01
- Primary completion
- 2023-05-23
- Completion
- 2023-05-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Quercetin | Small molecule | 1000 mg | Oral |
| Subject | dasatinib anhydrous | Small molecule | 100 mg | Oral |